These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2382 related articles for article (PubMed ID: 19725380)

  • 1. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dengue is a major global health problem. Foreword.
    Singhasivanon P; Jacobson J
    J Clin Virol; 2009 Oct; 46 Suppl 2():S1-2. PubMed ID: 19800558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress on sanofi pasteur's dengue vaccine candidate.
    Lang J
    J Clin Virol; 2009 Oct; 46 Suppl 2():S20-4. PubMed ID: 19800562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XXth century dengue pandemic: need for surveillance and research.
    Halstead SB
    World Health Stat Q; 1992; 45(2-3):292-8. PubMed ID: 1462664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue vaccines approach the finish line.
    Edelman R
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
    Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
    Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
    Capeding RZ; Luna IA; Bomasang E; Lupisan S; Lang J; Forrat R; Wartel A; Crevat D
    Vaccine; 2011 May; 29(22):3863-72. PubMed ID: 21477675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.
    Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
    Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.
    Guy B; Barrere B; Malinowski C; Saville M; Teyssou R; Lang J
    Vaccine; 2011 Sep; 29(42):7229-41. PubMed ID: 21745521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue vaccine.
    Simasathien S; Watanaveeradej V
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current malaria situation in Turkmenistan].
    Amangel'diev KA
    Med Parazitol (Mosk); 2001; (1):37-9. PubMed ID: 11548312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas.
    Pinheiro FP; Corber SJ
    World Health Stat Q; 1997; 50(3-4):161-9. PubMed ID: 9477544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Future prospects in developing of dengue vaccines].
    Valero N; Levy A
    Invest Clin; 2008 Jun; 49(2):135-8. PubMed ID: 18717261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of dengue virus and the development of a vaccine.
    Murrell S; Wu SC; Butler M
    Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
    Lam SK; Burke D; Capeding MR; Chong CK; Coudeville L; Farrar J; Gubler D; Hadinegoro SR; Hanna J; Lang J; Lee HL; Leo YS; Luong CQ; Mahoney R; McBride J; Mendez-Galvan J; Ng LC; Nimmannitya S; Ooi EE; Shepard D; Smit J; Teyssou R; Thomas L; Torresi J; Vasconcelos P; Wirawan DN; Yoksan S
    Vaccine; 2011 Nov; 29(51):9417-22. PubMed ID: 21864627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue vaccines for travelers.
    Wilder-Smith A; Deen JL
    Expert Rev Vaccines; 2008 Jul; 7(5):569-78. PubMed ID: 18564012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
    Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
    Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue surveillance in preparation for field vaccine trials.
    Letson GW
    J Clin Virol; 2009 Oct; 46 Suppl 2():S10-2. PubMed ID: 19800559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects.
    Guy B; Nougarede N; Begue S; Sanchez V; Souag N; Carre M; Chambonneau L; Morrisson DN; Shaw D; Qiao M; Dumas R; Lang J; Forrat R
    Vaccine; 2008 Oct; 26(45):5712-21. PubMed ID: 18762226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 120.